Press Releases (cont)
12 June 2007
Immtech And PAR Enter Licensing Agreement On Parfurmidine For Treatment Of Pneumocystis Pneumonia In The U.S.
09 April 2007
Immtech Initiates Phase IIb Clinical Trial to Develop Malaria Prevention and Treatment Therapies
09 February 2007
Immtech Reports Fiscal Third Quarter 2007 Results
07 February 2007
Immtech Announces Registered Offering of One Million Shares in Common Stock
30 January 2007
Immtech Completes Enrollment in Phase III Pivotal Trial of Pafuramidine for African Sleeping Sickness
24 January 2007
Patent Issued For Compounds With Potential To Treat BVDV And HCV
09 December 2006
Immtech Initiates Phase II of Pafuramidine Maleate (DB289) as a Prophylaxis for the Prevention of Malaria
21 November 2006
US FDA Grants Immtech's Oral Drug Candidate Pafuramidine (DB289) Orphan Drug Status for Treatment of PCP
10 November 2006
Immtech Investor Conference Call Scheduled For Tuesday, November 21, 2006
9 November 2006
Immtech Reports Fiscal Second Quarter 2007 Results
07 November 2006
Immtech Pharmaceuticals to Present at the BIO-Europe 2006 Conference
02 November 2006
Immtech Pharmaceuticals Among Fastest Growing Companies Named by Deloitte
25 October 2006
Immtech Adds New Board Member
12 October 2006
Immtech Pharmaceuticals Announces Antimicrobial Pipeline Progress
19 September 2006
Immtech Scientific Collaborators Receive $21.3 Million Bill and Melinda Gates Foundation Grant
23 August 2006
Immtech Taps Harvard Scientist And International Policy Expert Dr. Dorothy Zinberg As Consulting Strategic Advisor
09 August 2006
Immtech Reports Fiscal First Quarter 2007 Results
25 July 2006
Immtech Appoints Carol Ann Olson, MD To Senior Vice President Of Pharmaceutical Development And Chief Medical Officer
21 July 2006
Immtech Investor Conference Call Scheduled For Tuesday, July 25, 2006
21 July 2006
Patent Issued For Method To Manufacture Immtech's Drug Candidate Compounds
14 June 2006
Immtech Reports Fiscal Year End 2006 Results
12 June 2006
Immtech Investor Conference Call Scheduled for Wednesday, June 14, 2006
12 June 2006
Arbitral Tribunal Finds For Immtech
16 May 2006
Immtech Pharmaceuticals To Present At Rodman & Renshaw 3rd Annual Global Healthcare Conference
03 May 2006
Immtech Pharmaceuticals Announces Retirement of T. Stephen Thompson, President And Board Member
23 March 2006
Immtech International, Inc. becomes Immtech Pharmaceuticals, Inc.
13 March 2006
Immtech Announces DB289's Name "Pafuramidine Maleate"
Download the free Adobe Acrobat PDF reader.
Terms of Use | Privacy Policy
© 2008 Immtech. All Rights Reserved
